[1] |
CDC, “About Campylobacter infection,” Campylobacter Infection (Campylobacteriosis), 16-Jan-2025. [Online]. Available: https://www.cdc.gov/campylobacter/about/index.html. [Accessed: 18-Apr-2025]. |
[2] |
L. Jansen et al., “Campylobacteriosis outbreak linked to municipal water, Nebraska, USA, 20211,” Emerg. Infect. Dis., vol. 30, no. 10, pp. 1998–2005, 2024. |
[3] |
G. Caron, B. Viveiros, C. Slaten, D. Borkman, A. Miller, and R. C. Huard, “Campylobacter jejuni outbreak linked to raw oysters in Rhode Island, 2021,” J. Food Prot., vol. 86, no. 11, p. 100174, 2023. |
[4] |
M. P. Montgomery et al., “Multidrug-resistant Campylobacter jejuni outbreak linked to puppy exposure – United States, 2016-2018,” MMWR Morb. Mortal. Wkly. Rep., vol. 67, no. 37, pp. 1032–1035, 2018. |
[5] |
L. Davis and V. DiRita, “Growth and laboratory maintenance of Campylobacter jejuni: Epsilon Proteobacteria,” Curr. Protoc. Microbiol., vol. Chapter 8, no. 1, p. Unit 8A.1.1-8A.1.7, 2008. |
[6] |
A. Flint, Y.-Q. Sun, and A. Stintzi, “Cj1386 is an ankyrin-containing protein involved in heme trafficking to catalase in Campylobacter jejuni,” J. Bacteriol., vol. 194, no. 2, pp. 334–345, 2012. |
[7] |
N. O. Kaakoush, N. Castaño-Rodríguez, H. M. Mitchell, and S. M. Man, “Global epidemiology of Campylobacter infection,” Clin. Microbiol. Rev., vol. 28, no. 3, pp. 687–720, 2015. |
[8] |
D. Chen, A. H. Havelaar, J. A. Platts-Mills, and Y. Yang, “Acquisition and clearance dynamics of Campylobacter spp. in children in low- and middle-income countries,” Epidemics, vol. 46, no. 100749, p. 100749, 2024. |
[9] |
“Antibiotic resistance,” Cdc.gov, 27-Jun-2022. [Online]. Available: https://archive.cdc.gov/www_cdc_gov/campylobacter/campy-antibiotic-resistance.html. [Accessed: 18-Apr-2025]. |
[10] |
Y. Doorduyn, W. E. Van Den Brandhof, Y. T. H. P. Van Duynhoven, B. J. Breukink, J. A. Wagenaar, and W. Van Pelt, “Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study,” Epidemiol. Infect., vol. 138, no. 10, pp. 1391–1404, 2010. |
[11] |
CDC, “Clinical overview of Campylobacter,” Campylobacter Infection (Campylobacteriosis), 30-Jan-2025. [Online]. Available: https://www.cdc.gov/campylobacter/hcp/clinical-overview/index.html. [Accessed: 18-Apr-2025]. |
[12] |
D. R. Snydman, “Campylobacter gastroenteritis,” Am. Fam. Physician, vol. 25, no. 1, pp. 133–136, 1982. |
[13] |
D. Schönberg-Norio et al., “Patient-reported complications associated with Campylobacter jejuni infection,” Epidemiol. Infect., vol. 138, no. 7, pp. 1004–1011, 2010. |
[14] |
N. Latov, “Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy,” Microorganisms, vol. 10, no. 11, p. 2139, 2022. |
[15] |
N. Shahrizaila, H. C. Lehmann, and S. Kuwabara, “Guillain-Barré syndrome,” Lancet, vol. 397, no. 10280, pp. 1214–1228, 2021. |
[16] |
J. L. Smith, “Campylobacter jejuni infection during pregnancy: long-term consequences of associated bacteremia, Guillain-Barré syndrome, and reactive arthritist,” J. Food Prot., vol. 65, no. 4, pp. 696–708, 2002. |
[17] |
M. S. Pasternack, “Impact and management of Campylobacter in human medicine–US perspective,” Int. J. Infect. Dis., vol. 6 Suppl 3, pp. 3S37-42; discussion 3S42-3, 3S53-8, 2002. |
[18] |
N. Özcan, F. Bacalan, F. Çakır, A. Bilden, N. Genişel, and T. Dal, “Culture and culture-independent diagnostic tests in Campylobacter enteritis,” J. Infect. Dev. Ctries., vol. 16, no. 4, pp. 616–621, 2022. |
[19] |
CDC, “Treatment of Campylobacter infection,” Campylobacter Infection (Campylobacteriosis), 17-Sep-2024. [Online]. Available: https://www.cdc.gov/campylobacter/treatment/index.html. [Accessed: 18-Apr-2025]. |
[20] |
L. S. Eiland and L. S. Jenkins, “Optimal treatment of campylobacter dysentery,” J. Pediatr. Pharmacol. Ther., vol. 13, no. 3, pp. 170–174, 2008. |
[21] |
C. Hoelzl, U. Mayerhofer, M. Steininger, W. Brüller, D. Hofstädter, and U. Aldrian, “Observational trial of safe food handling behavior during food preparation using the example of Campylobacter spp,” J. Food Prot., vol. 76, no. 3, pp. 482–489, 2013. |
[22] |
P. L. White, A. R. Baker, and W. O. James, “Strategies to control Salmonella and Campylobacter in raw poultry products,” Rev. Sci. Tech., vol. 16, no. 2, pp. 525–541, 1997. |
[23] |
M. Meunier, M. Guyard-Nicodème, D. Dory, and M. Chemaly, “Control strategies against Campylobacter at the poultry production level: biosecurity measures, feed additives and vaccination,” J. Appl. Microbiol., vol. 120, no. 5, pp. 1139–1173, 2016. |
[24] |
D. Hermans et al., “Passive immunization to reduce Campylobacter jejuni colonization and transmission in broiler chickens,” Vet. Res., vol. 45, p. 27, 2014. |